Public Company News
CStone Updated Clinical Progress and Key Phase I/II Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)
Key Highlights: * Excellent Safety Profile: As of mid-March 2026, 113 heavily pretreated patients with solid tumors have been enrolled in the Phase I trial of CS2009, with a median follow-up of approximately 6 months. The more mature data continue to show a favorable safety profile, with23% i...
Peijia Medical Announces 2025 Annual Results
SUZHOU, China, March 26, 2026 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced its annual results for the year ended December 31, 2025 on March 25, 2026. During th...
Samsung Biologics Recognized for Advancing Sustainability at 2026 CDMO Leadership Awards
* Reinforcing long-term commitment to embedding sustainability across operations and partnerships * Continuing to support clients in delivering high-quality, life-saving medicines to patients worldwide INCHEON, South Korea, March 26, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a ...
Highway Holdings Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
HONG KONG, March 26, 2026 /PRNewswire/ -- Highway Holdings Limited (Nasdaq: HIHO, the "Company" or "Highway Holdings") today announced that on March 17, 2026,Highway Holdings Limited (the "Company") received a written notification (the "Notification Letter") from the Listing Qualifications Depart...
Innovent Announces 2025 Annual Results and Business Updates
From China Leadership to Global Premier: Revenue Surpasses RMB 10 Billion, Entering the Era of Profitability and Globalization SAN FRANCISCO and SUZHOU, China, March 26, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develop...
GC Biopharma Receives Marketing Authorization for Varicella Vaccine 'BARYCELA Inj.' in Guatemala
- First regulatory clearance in Latin America marks a strategic milestone for regional market expansion - World's first antibiotic-free manufacturing process ensures superior safety profile YONGIN, South Korea, March 26, 2026 /PRNewswire/ -- GC Biopharma(006280.KS), a leading provider of biophar...
LG Leadership Emphasizes 'Speed' as the Core Driver in the AX Era
SEOUL, South Korea, March 26, 2026 /PRNewswire/ -- LG hosted a President's
Meeting on the 25th at the Namsan Leadership Center in Seoul, attended by LG
Corp. Chairman and CEO Kwang-mo Koo and about 40 top executives from major
affiliates.
Hengrui Pharma Announces Strong 2025 Annual Results
SHANGHAI, March 25, 2026 /PRNewswire/ -- On March 25, 2026, Hengrui Pharma (600276.SH; 01276.HK) announced robust financial results for the full year 2025, fueled by its dual strategy of innovation and globalization. Revenue increased 13% year-on-year to RMB 31.63 billion, and net profit attribut...
Health In Tech Announces $7.0 Million Private Placement
STUART, Fla., March 25, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company"), an AI-enabled InsurTech platform company, today announced that it has entered into a securities purchase agreement for a private investment in public equity financing (the "PIPE") ...
X Financial Reports Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results
SHENZHEN, China, March 25, 2026 /PRNewswire/ -- X Financial (NYSE: XYF), a leading Chinesefintech platform, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. This press release should be read in conjunction with the Company's Report on...
OLLOBOT Prepares August Kickstarter Launch for Enhanced OlloNi Following Strong CES 2026 Debut
LAS VEGAS, March 25, 2026 /PRNewswire/ -- OLLOBOT,
RoboSense Beat Expectations, Achieved First-Ever Quarterly Profit on Strong Robotics Growth
* Achieved the first-ever quarterly net profit in Q4 2025, reaching approximately RMB 104 million, significantly exceeding market expectations. * Quarterly LiDAR sales volume for robotics and others experienced explosive growth in Q4 2025, with total shipments reaching approximately 221,200 un...
Clarity signs a large-scale Manufacturing Supply Agreement for copper-64 with Theragenics
SYDNEY, March 25, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a lar...
GIBO Expands GIBO Watch with "Digital Canvas" -- A Next-Generation Generative Pipeline for Short Film Creation
KUALA LUMPUR, Malaysia, March 25, 2026 /PRNewswire/ -- GIBO Holdings Ltd. (NASDAQ: GIBO), a global technology company focused on AI-driven content infrastructure, today announced the launch of the"Digital Canvas" within its GIBO Watch framework—a next-generation generative pipeline designed to em...
K-Beauty Manufacturer KM Pharmaceutical (KOSDAQ: 225430) Expands Global Skincare and Oral Care OEM/ODM Platform with Advanced Functional Product Portfolio
SEOUL, South Korea, March 25, 2026 /PRNewswire/ -- KM Pharmaceutical Co., Ltd. (KOSDAQ: 225430), a leading K-beauty manufacturer specializing in skincare, oral care, and private label OEM/ODM production, is strengthening its global position by expanding into high-value functional product categori...
TOYO Co., Ltd Schedules Second Half and Fiscal Year 2025 Earnings Release and Conference Call Date
TOKYO, March 25, 2026 /PRNewswire/ -- TOYO Co., Ltd
Erayak Strategic Roadmap: Providing a High-Precision Energy Defense Against Global Oil and Grid Volatility
Optimizing Tri-Fuel "Infinite Runtime" and Utility-Grade Power Quality to
Shield Modern Households from Energy Crises
WENZHOU, China, March 25, 2026 /PRNewswire/ -- Erayak Power Solution Group
Inc. (Nasdaq: RAYA) ("Erayak" or the "Company"), a leading developer of
Cheche Group Schedules Second Half and FY 2025 Earnings Release and Conference Call Date
BEIJING, March 25, 2026 /PRNewswire/ -- Cheche Group Inc.
LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company
BEIJING, March 25, 2026 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics ...
Nota AI and SiMa.ai Sign Strategic Partnership for Physical AI Technology Collaboration
"Combining AI Optimization with High Performance and Efficiency MLSoCs to Lead the Physical AI Market" * Nota AI's AI Optimization Technology Meets SiMa.ai's MLSoC™ Product Family, Maximizing On-Device AI Performance for Physical AI * Joint Development and Commercialization of AI Solutions fo...
Week's Top Stories
Most Reposted
TotalEnergies ENEOS Extends Solar Partnership with Ceres in Indonesia
[Picked up by 317 media titles]
2026-06-08 10:16Visa Partners with OpenAI to Power the Next Generation of AI Commerce
[Picked up by 304 media titles]
2026-06-11 09:30QuettaFlow Technologies Strengthens Global Strategic Alliance with Lead Wealth and Showcases VasEdge at COMPUTEX Taipei 2026
[Picked up by 294 media titles]
2026-06-11 10:00Omni HR Launches Mino, the First AI Agent Built on Unified APAC HR Data
[Picked up by 286 media titles]
2026-06-08 09:00HKC, ANTGAMER, KOORUI Make Strong Debut at COMPUTEX 2026 with World-First Display Innovations
[Picked up by 279 media titles]
2026-06-10 11:13